NanoEntek's latest marketcap:
As of 11/13/2025, NanoEntek's market capitalization has reached $84.44 M. According to our data, NanoEntek is the 26571th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 84.44 M |
| Revenue (ttm) | 23.18 M |
| Net Income (ttm) | 1.2 M |
| Shares Out | 38.09 M |
| EPS (ttm) | 0.04 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2003 |
| Earnings Date | 11/14/2025 |
NanoEntek's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 11/13/2025 | ₩124.18 B | $84.44 M | 15.53% | 26571 |
| 12/30/2024 | ₩104.52 B | $70.03 M | 4.81% | 25656 |
| 12/28/2023 | ₩99.72 B | $76.79 M | -37.48% | 24857 |
| 12/29/2022 | ₩159.51 B | $126.01 M | -20.11% | 20804 |
| 12/30/2021 | ₩199.66 B | $167.72 M | -13.56% | 19896 |
| 12/30/2020 | ₩230.98 B | $212.51 M | 54.9% | 16436 |
| 12/30/2019 | ₩149.11 B | $128.24 M | 33.92% | 16860 |
| 12/28/2018 | ₩111.35 B | $99.1 M | -23.52% | 17303 |
| 12/28/2017 | ₩145.59 B | $135.39 M | 18.67% | 16457 |
| 12/29/2016 | ₩122.68 B | $100.6 M | -30.95% | 15923 |
Company Profile
About NanoEntek, Inc.
NanoEntek, Inc. is a leading company specializing in life-science lab equipment, in vitro diagnostic medical devices, and point-of-care diagnostic solutions. Headquartered in Seoul, South Korea, the company operates both domestically and internationally, focusing on innovative research, development, and production.
Key Products and Solutions
- FREND System: A fluorescence immunoassay analyzer for accurate diagnostics.
- BUDDI: A rapid diagnostic test analyzer for efficient testing.
- Rapid Diagnostic Test Items: High-quality diagnostic solutions for various applications.
- ADAM-rWBC: Residual white blood cell counters for precise cell analysis.
- ADAMII/Fluorescence Stem Cell Counter: Advanced tools for stem cell research.
- Fluorescence Cell Counters & Analyzers: Cutting-edge technology for cell analysis.
- Brightfield Cell Counters: Reliable instruments for laboratory use.
- Somatic Cell Counters: Essential for dairy and food safety testing.
- Live-Cell Imaging System: Enables real-time monitoring of cell behavior.
- Disposable Hemocytometers: Convenient and hygienic cell-counting solutions.
Company Background
Founded in 1987, NanoEntek has established itself as a trusted provider of diagnostic and laboratory equipment, serving healthcare and research communities worldwide.
Frequently Asked Questions
-
What is NanoEntek's (KOSDAQ-039860) current market cap?As of 11/13/2025, NanoEntek (including the parent company, if applicable) has an estimated market capitalization of $84.44 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does NanoEntek (KOSDAQ-039860) rank globally by market cap?NanoEntek global market capitalization ranking is approximately 26571 as of 11/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.